HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!

Slides:



Advertisements
Similar presentations
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
Advertisements

Essential Documentation GCP Training Seminar 12th October 2011
Tips to a Successful Monitoring Visit
GCP for Investigators Tina Lidén Mascher, Kvalitetsregister, forskning och industrisamarbeten.
Review Questions Business 205
Managing Regulatory Documents Electronically
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
GMP Document and Record Retention
Good Clinical Practices Regulatory Guidelines for the Conduct of Clinical research Introduction to Research Pharmacy Services Javier Palacios, R.Ph. Sponsored.
Coping with Electronic Records Setting Standards for Private Sector E-records Retention.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Instructions and forms
Records Survey and Retention Schedule Recertification 2011.
Regulatory Overview.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
“So You Think You Know GCP …” Session S794 Jill Matzat, RN, BSN, CCRA, CCRT President, Medical Research Management & CRA Solutions, Inc. Paul Below, CCRA,
Policy on Data Stewardship, Access, and Retention Establishes University policy to assure that research data are appropriately maintained, archived for.
Nikki Dillard Allison Lowry Tiffany Thomas.  “The maintenance of a history of one’s activities, as financial dealings, by entering data into ledgers.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
STUDY CLOSE OUT KEMRI-Wellcome Trust Research Programme Version: 4-Nov-2008.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
RECORDS MANAGEMENT Office of Compliance. OBJECTIVES Four main objectives of a Records Management Program: –Increase efficiency of record keeping. –Protection.
Ecords Management Records Management Paul Smallcombe Records & Information Compliance Manager.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Introduction to the new SHC Health Information Record Manual Presented by Rhonda Anderson, RHIA President Anderson Health Information Systems, Inc
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
ANJALI JADHAV ANKITA SINGH ANUJA AHIRE ANURADHA PRASAD BEVIN D’SOUZA.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
Leslie Howes, MPH, CIP Alyssa Speier, MS, CIP September 24, 2014 Investigator Manual: ra/investigator-manual/
ISO DOCUMENTATION. ISO Environmental Management Systems2 Lesson Learning Goals At the end of this lesson you should be able to:  Name.
SCHOOLS FINANCE OFFICERS MEETINGS Records Management, “Paper-Lite” Environments and Procedures when a school closes Elizabeth Barber.
IP Accountability in Outpatient Clinical Trials
RECORDS MANAGEMENT Office of Business Affairs. OBJECTIVES Four main objectives of a Records Management Program: –Increase efficiency of record keeping.
ISO RECORDS. ISO Environmental Management Systems2 Lesson Learning Goals At the end of this lesson you should be able to:  Describe.
University Retention Schedule Training. Introduction to the University Retention Schedule.
Project management Topic 8 Configuration Management.
Good Clinical Practice (GCP) UKTMN 6 th June 2006.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Trial Master Files – the De-Centralised Communication Challenge Karen Roy.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
IP Accountability in Outpatient Clinical Trials Jessica Rinaldi, CCRP Farber Institute for Neurosciences.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Briefing on MHRA routine inspection of non-commercial clinical trials
Study Closure What Happens Next?
BSB Biomanufacturing CHAPTER 4 GMP – Documentation Part I (SOP)
Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
Field Inventory Services-Sanofi Inventory and Audit Training
Alyssa Speier, MS, CIP November 13, 2013
Data Managers’ Forum What’s in it for us?
GCP Refresher for Investigators
Regulatory Binder: Maintaining Essential Study Documentation
Basics of Building and Understanding Data Collection Forms
Gilbert Ogetii KEMRI-Wellcome Trust Research Programme Kilifi, Kenya
Good Laboratory Practices
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Site File Management. Julie James, Aldona Kirkham Anne Moore UHL Clinical Trial Monitors and Trainers Sept 2017.
Radiopharmaceutical Production
OSU Controlled Substances Training Module for Researchers
Good clinical practice
S A Overarching SOPs Funding Secured Training Records
Presentation transcript:

HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!

Document Retention Legal requirement for a Clinical Trial of an Investigational Medical Product  Essential documents should be retained by the PI until informed by the sponsor that they are no longer needed (written agreement obtained)  The sponsor and the Chief Investigator shall ensure that the documents contained in the trial master file and the medical files of subjects are kept for at least 5 years from defined start point of archiving.  Sponsor to appoint named individuals responsible for archive (restricted access to those individuals)

Essential Documents UK Regulations 2006  Enable both the conduct of the clinical trial and the quality of the data produced to be evaluated  Show whether the trial is or has been conducted in accordance with applicable requirements  Shall contain information relating to each phase of the trial (before, during, after) eg, minutes, training records, calibration records, statistical reports  Sponsor shall keep a Trial Master File  Should be filed in an organised way that will facilitate management, audit and inspection of the trial

Archiving  Complete and legible with a validated system of transfer to other media (eg. floppy discs in 20 years may not be)  Suitable space with appropriate environmental control and protection from physical damage  Archive index/log maintained to track documents  Named Investigator responsible for archiving essential documents and should inform sponsor if responsibility transferred due to eg. relocation or retirement

SRHT SOP 009 (2007)   All trial data must be kept so that the data can be accessed after the trial has finished.   Good Clinical Practice Guidelines specify which documents are essential for a clinical trial.   For commercial trials documentation needs to be retained for at least 15 years. (ICH GCP guidelines)

 Documentation can be archived by the PI or the sponsor.  If the PI leaves or changes during the archival period a handover of responsibility must be documented.  Archiving must be done as soon as possible after the completion of a study – but can be ongoing throughout the trial.  Material should be stored correctly – in labelled archive boxes.

Example of Label   Sponsor Name, Protocol Number, Ethics Number   Protocol Title   Principal Investigator, Co-Investigator & Contact details   Department X, Hospital   Box [insert number] of [insert total number]   (Brief description of content)   Archive from [insert date] until [insert date]   PDF created

Storage  Secure - Access is limited to PI, Sponsors and regulatory authorities.  Under constant environmental conditions – temperature, humidity and pest control.  Archive log - Retrieval of items etc.

Example of archiving log   Sponsor Name   Protocol Number   Ethics Number _ _ _ / _ _   Protocol Title   Investigator   Directorate   Please detail below the Case Record Form Numbers   Please indicate the number of archiving boxes, specific contents per box and exact   storage location   Contents of Box Storage Location   Box 1   Box 2   Box 3   Box 4   Box 5   Box 6   · Archive storage labels should be put on each storage box   · Any details regarding a change in storage during the archiving period should be   documented   · The Investigator Declaration should be completed   · This log should be stored in a specified location by   Principal Investigator Declaration   · All essential documents are filed within the Investigator File as per the requirements   of ICH-GCP   · All consent forms are in the Investigator File in numerical order   · The archive boxes will be stored as per requirements to conform to ICH-GCP   Principal Investigator signature…………………………………………………………...   Date:……………………………………………………………………………………   PDF

Medical / Pharmacy records  Participant’ clinical notes must also be retained – can be as electronic format.  Pharmacy records if drug trial must also be retained.  Company data relating to trial orthopaedic implants for example must also be retained.

Destruction of Data  Data is destroyed according to guidelines.  A record of destruction of essential documentation needs to be kept for a further 5 years from destruction date.  Details of data should be available at any time for Regulatory bodies to inspect.